Although there was no statistically significant difference between PR3-ANCA in disease severity or progression as measured by the presence of cirrhosis, esophageal varices, hepatic encephalopathy, or ascites, the relative number of these patients in the cohort was low. The gene discussed is PRTN3; the disease is Cirrhosis.